A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

Cited by (756)

Items 301–400 of 756

1. A Chimeric Plasmodium falciparum Merozoite Surface Protein Vaccine Induces High Titers of Parasite Growth Inhibitory Antibodies
   James R. Alaro, Andrea T. Partridge, Kazutoyo Miura, Ababacar Diouf, Ana M. Lopez, Evelina Angov, Carole A. Long, James M. Burns · 2013 · Infection and Immunity
2. You Shall Not Pass: Memory CD8 T Cells in Liver-Stage Malaria
   Mitchell N. Lefebvre, John T. Harty · 2019 · Trends in Parasitology
3. Phase I assessments of first-in-human administration of a novel malaria anti-sporozoite vaccine candidate, R21 in matrix-M adjuvant, in UK and Burkinabe volunteers
   Navin Venkatraman, Alfred B. Tiono, Georgina Bowyer, Jonathan Powlson, Katharine A. Collins, Sam Aboubacar Coulibaly, Mehreen S. Datoo, Daniel Silman, Alphonse Ouédraogo, Issa Nébié et al. · 2019 · medRxiv
4. Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection
   Kelly E. Seaton, Rachel L. Spreng, Milite Abraha, Matthew Reichartz, Michelle Rojas, Frederick Feely, Richard H.C. Huntwork, Sheetij Dutta, Sarah V. Mudrak, S. Munir Alam et al. · 2021 · npj Vaccines
5. Malaria hospitalisation in East Africa: age, phenotype and transmission intensity
   Alice Kamau, Robert Stephen Paton, Samuel Akech, Arthur Mpimbaza, Cynthia Khazenzi, Morris Ondieki Ogero, Eda Mumo, Victor A. Alegana, Ambrose Agweyu, Neema Mturi et al. · 2022 · BMC Medicine
6. Tryptophan C-mannosylation is critical for Plasmodium falciparum transmission
   Lopaticki, Sash, McConville, Robyn, John, Alan, Geoghegan, Niall, Mohamed, Shihab Deen, Verzier, Lisa, Steel, Ryan W. J., Evelyn, Cindy, O’Neill, Matthew T., Soler, Niccolay Madiedo et al. · 2022 · Nature Communications
7. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses
   Thomas Powell, Jie Ting Tang, Mary DeRome, Robert A. Mitchell, Andrea Jacobs, Yanhong Deng, Naveen Palath, Edwin Cardenas, James G. Boyd, Elizabeth Higgins Nardin · 2013 · Vaccine
8. Application of a Scalable Plant Transient Gene Expression Platform for Malaria Vaccine Development
   Holger Spiegel, Alexander Boes, Nadja Voepel, Veronique Beiss, Gueven Edgue, Thomas Rademacher, M. Sack, Stefan Schillberg, Andreas Reimann, Rainer Fischer · 2015 · Frontiers in Plant Science
9. Is maternal education a social vaccine for childhood malaria infection? A cross-sectional study from war-torn Democratic Republic of Congo
   Cary Ma, K. M. Claude, Z. Kibendelwa, Hannah M. Brooks, Xiao Zheng, M. Hawkes · 2017 · Pathogens and Global Health
10. Structural ordering of the Plasmodium berghei circumsporozoite protein repeats by inhibitory antibody 3D11
    Iga Kucharska, Elaine Thai, Ananya Srivastava, John L. Rubinstein, Régis Pomès, Jean‐Philippe Julien · 2020 · eLife
11. Tissues: the unexplored frontier of antibody mediated immunity
    Nicholas E. Webb, Biana Bernshtein, Galit Alter · 2021 · Current Opinion in Virology
12. Implications of Plasmodium Glycosylation on Vaccine Efficacy and Design
    Ethan D. Goddard‐Borger, Justin A. Boddey · 2018 · Future Microbiology
13. Modeling malaria in humanized mice: opportunities and challenges
    Evelyn Siu, Alexander Ploß · 2015 · Annals of the New York Academy of Sciences
14. The malaria vaccine – Status quo 2013
    D. Gray Heppner · 2013 · Travel Medicine and Infectious Disease
15. A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments
    Arif Jamal Siddiqui, Jyoti Bhardwaj, Juhi Saxena, Sadaf Jahan, Mejdi Snoussi, Fevzi Bardakçi, Riadh Badraoui, Mohd Adnan · 2023 · Vaccines
16. Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence
    M. Gabriela M. Gomes, Stephen B. Gordon, David Griffith Lalloo · 2016 · Vaccine
17. Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants
    Rodrigo Nunes Rodrigues‐da‐Silva, Isabela Ferreira Soares, César López‐Camacho, João Hermínio Martins da Silva, Daiana de Souza Perce-da-Silva, Antônio Têva, Antônia Maria Ramos Franco, Francimeire Gomes Pinheiro, Lana Bitencourt Chaves, Lilian Rose Pratt-Riccio et al. · 2017 · Frontiers in Immunology
18. Inhibitor of Cysteine Proteases Is Critical for Motility and Infectivity of Plasmodium Sporozoites
    Katja E. Boysen, Kai Matuschewski · 2013 · mBio
19. Editorial: Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030
    Dinah V. Parums · 2023 · Medical Science Monitor
20. Malaria Vaccines: Moving Forward After Encouraging First Steps
    Tuan M. Tran, Sílvia Portugal, Simon J. Draper, Peter D. Crompton · 2015 · Current Tropical Medicine Reports
21. Immunogenicity of Recombinant Proteins Consisting of Plasmodium vivax Circumsporozoite Protein Allelic Variant-Derived Epitopes Fused with Salmonella enterica Serovar Typhimurium Flagellin
    Monica T. Leal, Ariane Guglielmi Ariza Camacho, Laís Helena Teixeira, Daniel Y. Bargieri, Irene S. Soares, Cibele Aparecida Tararam, Mauricio Martins Rodrigues · 2013 · Clinical and Vaccine Immunology
22. Malaria, dengue and chikungunya in India – An update
    Siva Santosh Kumar Pentapati, M. C. Arjun, Sanjeev Gupta, Baridalyne Nongkynrih · 2017 · Indian Journal of Medical Specialities
23. The challenges of a circumsporozoite protein-based malaria vaccine
    Deepyan Chatterjee, Ian Andrew Cockburn · 2021 · Expert Review of Vaccines
24. A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria
    Yu-Min Chuang, Mohamad‐Gabriel Alameh, Selma Abouneameh, Hamidah Raduwan, Michel Ledizet, Drew Weissman, Erol Fikrig · 2023 · npj Vaccines
25. Future use-cases of vaccines in malaria control and elimination
    Melissa A. Penny, Flavia Camponovo, Nakul Chitnis, Thomas A. Smith, Marcel Tanner · 2020 · Parasite Epidemiology and Control
26. Antigenicity and immunogenicity of a novel chimeric peptide antigen based on the P. vivax circumsporozoite protein
    Nora Céspedes, Myriam Arévalo‐Herrera, Ingrid Felger, Steve Reed, Andrey V. Kajava, Giampietro Corradin, Sócrates Herrera · 2013 · Vaccine
27. Mind the gap: jumping from vaccine licensure to routine use
    Katherine L. O’Brien, Fred Newton Binka, Kevin Marsh, Jon S. Abramson · 2016 · The Lancet
28. Malaria (Plasmodium Species)
    Rick M. Fairhurst, Thomas E. Wellems · 2015 · Elsevier eBooks
29. Porcine epidemic diarrhea virus virus-like particles produced in insect cells induce specific immune responses in mice
    Cuiling Wang, Feihu Yan, Xuexing Zheng, Hualei Wang, Hongli Jin, Chong Wang, Yongkun Zhao, Na Feng, Tiecheng Wang, Yuwei Gao et al. · 2017 · Virus Genes
30. Frequent inoculations with radiation attenuated sporozoite is essential for inducing sterile protection that correlates with a threshold level of Plasmodia liver-stage specific CD8+ T cells.
    Hardik Patel, Naveen Yadav, R. Parmar, Satish D. Patel, Agam P Singh, N. Shrivastava, S. Dalai · 2017 · Cellular Immunology
31. In Vitro Antimalarial Activity of Novel Semisynthetic Nocathiacin I Antibiotics
    Indu Sharma, Margery Sullivan, Thomas F. McCutchan · 2015 · Antimicrobial Agents and Chemotherapy
32. Economic analyses of vaccine policies
    Mark A. Miller, Alan R. Hinman · 2013 · Elsevier eBooks
33. Developing vaccines to prevent malaria in pregnant women
    Nicaise Tuikue Ndam, Philippe Deloron · 2015 · Expert Opinion on Biological Therapy
34. Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines
    Aloysious Ssemaganda, Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczyński, István Tóth, Danielle I. Stanisic, Michael F. Good · 2019 · Frontiers in Immunology
35. In vivo CD8+ T Cell Dynamics in the Liver of Plasmodium yoelii Immunized and Infected Mice
    Mynthia Cabrera, Lecia L. Pewe, John T. Harty, Ute Frevert · 2013 · PLoS ONE
36. New insight-guided approaches to detect, cure, prevent and eliminate malaria
    Sushil Kumar, Renu Kumari, Richa Pandey · 2014 · PROTOPLASMA
37. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein
    Min Zhang, Izumi Kaneko, Tiffany Tsao, Robert A. Mitchell, Elizabeth Higgins Nardin, Shiroh Iwanaga, Masao Yuda, Moriya Tsuji · 2016 · Malaria Journal
38. The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primates
    Parham Ramezani-Rad, Ester Marina-Zárate, Laura Maiorino, Amber Myers, Katarzyna Kaczmarek Michaels, Ivan Susin Pires, Nathaniel I. Bloom, Mariane B. Melo, Ashley A. Lemnios, Paul G. Lopez et al. · 2025 · Journal of Clinical Investigation
39. Developing inexpensive malaria vaccines from plants and algae
    James A. Gregory, Stephen Patrick Mayfield · 2014 · Applied Microbiology and Biotechnology
40. Towards functional antibody-based vaccines to prevent pre-erythrocytic malaria infection
    Brandon K. Sack, Stefan H. I. Kappe, D. Noah Sather · 2017 · Expert Review of Vaccines
41. Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
    Lucas Otieno, Yolanda Guerra Mendoza, Samuel Adjei, Tsiri Agbenyega, Sélidji Todagbé Agnandji, Pedro Aíde, Pauline Akoo, Daniel Ansong, Kwaku Poku Asante, James Alexander Berkley et al. · 2019 · Vaccine
42. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus
    Milena Mazalovska, Joseph Calvin Kouokam · 2020 · Viruses
43. The potential role of Punica granatum treatment on murine malaria-induced hepatic injury and oxidative stress
    Taghreed A. Hafiz, Murad A. Mubaraki, Saleh Al‐Quraishy, Mohamed A. Dkhil · 2015 · Parasitology Research
44. Text recycling in health sciences research literature: a rhetorical perspective
    Cary A. Moskovitz · 2017 · Research Integrity and Peer Review
45. RTS,S/AS01 Malaria Vaccine Efficacy is Not Modified by Seasonal Precipitation: Results from a Phase 3 Randomized Controlled Trial in Malawi
    Larry Han, Michael G. Hudgens, Michael Emch, Jonathan J. Juliano, Corinna Keeler, Francis E. A. Martinson, Portia Kamthunzi, Gerald Tegha, Marc Lievens, Irving Hoffman · 2017 · Scientific Reports
46. Cause-specific mortality in the Kombewa health and demographic surveillance systems site, rural Western Kenya from 2011–2015
    Peter Sifuna, Lucas Otieno, Sheila Ogwang, Bernhards Ragama Ogutu, Ben M. Andagalu, John Owuoth, Valentine Sing’oei, Jessica Cowden, Walter Otieno · 2018 · Global Health Action
47. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase
    Sneha Dutta, Aneesha G. Tewari, Chinthapalli Balaji, Reena Verma, Anasuya Moitra, Mamta Yadav, Prakhar Agrawal, Dinkar Sahal, Gotam K. Jarori · 2018 · Malaria Journal
48. Estimating and Testing Vaccine Sieve Effects Using Machine Learning
    David C. Benkeser, Peter B. Gilbert, Marco Carone · 2018 · Journal of the American Statistical Association
49. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys
    James M. Burns, Kazutoyo Miura, JoAnn S. Sullivan, Carole A. Long, John W. Barnwell · 2016 · Malaria Journal
50. Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi
    Sundos Khan, Matthew Parrillo, Andrés H. Gutiérrez, Frances E. Terry, Leonard Moise, William D Martin, Anne Searls De Groot · 2019 · Human Vaccines & Immunotherapeutics
51. Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection Trials
    William Chad Young, Lindsay N. Carpp, Sidhartha Chaudhury, Jason A. Regules, Elke S. Bergmann‐Leitner, Christian F. Ockenhouse, Ulrike Wille-Reece, Allan C. deCamp, Ellis Hughes, Celia R. Mahoney et al. · 2021 · Frontiers in Big Data
52. Leveraging Immunopeptidomics To Study and Combat Infectious Disease
    Owen K. Leddy, Forest M. White, Bryan D. Bryson · 2021 · mSystems
53. Coadministration of Polyinosinic:Polycytidylic Acid and Immunostimulatory Complexes Modifies Antigen Processing in Dendritic Cell Subsets and Enhances HIV Gag-Specific T Cell Immunity
    Kylie M. Quinn, Ayako Yamamoto, Andréia da Silva Costa, Patricia A. Darrah, Ross W. B. Lindsay, Sonia Tara Hegde, Teresa R. Johnson, Barbara J. Flynn, Karin Loré, Robert A. Seder · 2013 · The Journal of Immunology
54. Unique features of apicoplast DNA gyrases from Toxoplasma gondii and Plasmodium falciparum
    S. Nagano, Ting‐Yu Lin, Jyotheeswara Reddy Edula, Jonathan G. Heddle · 2014 · BMC Bioinformatics
55. Genome- and proteome-wide screening strategies for antigen discovery and immunogen design
    Sophie Schussek, Angela Trieu, Denise L. Doolan · 2014 · Biotechnology Advances
56. Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial
    Innocent Valéa, Samuel Adjei, Effua Abigail Usuf, Ousmane Traoré, Daniel Ansong, Halidou Tinto, Harry Owusu Boateng, Amanda Jane Leach, M. Athanase Somé, Patrick Boakye Yiadom Buabeng et al. · 2018 · Human Vaccines & Immunotherapeutics
57. Malaria
    Nicholas John White · 2013 · Elsevier eBooks
58. Malaria Vaccine Trials — Beyond Efficacy End Points
    Johanna Patricia Daily · 2012 · New England Journal of Medicine
59. Serum Cytokine Profiles Associated with Specific Adjuvants Used in a DNA Prime-Protein Boost Vaccination Strategy
    Rachel Buglione‐Corbett, Kimberly Pouliot, Robyn Marty-Roix, Kim West, Shixia Wang, Egil Lien, Shan Lu · 2013 · PLoS ONE
60. Host genetics in malaria: lessons from mouse studies
    Hong Huang, Brendan John McMorran, Simon J. Foote, Gaétan Burgio · 2018 · Mammalian Genome
61. The Systematic Review and Meta-Analysis on the Immunogenicity and Safety of the Tuberculosis Subunit Vaccines M72/AS01E and MVA85A
    Inayat Ullah, Shaheen Bibi, Ijaz ul Haq, Safia, Kifayat Ullah, Long Ge, Xintong Shi, Bin Ma, Hongxia Niu, Jinhui Tian et al. · 2020 · Frontiers in Immunology
62. Acceptance of and Adherence to a Four-Dose RTS,S/AS01 Schedule: Findings from a Longitudinal Qualitative Evaluation Study for the Malaria Vaccine Implementation Programme
    Jessica Price, Nikki Gurley, M. Gyapong, E. Ansah, K. Awusabo-Asare, S. Gyasi, Pearson Nkhoma, A. Nyondo-Mipando, George Okello, J. Webster et al. · 2023 · Vaccines
63. Chemical Attenuation of Plasmodium in the Liver Modulates Severe Malaria Disease Progression
    Matthew D. Lewis, Jochen Behrends, Cláudia Sá e Cunha, António M. Mendes, Felix Lasitschka, Julia Magdalena Sattler, Kirsten Heiß, Taco W. A. Kooij, Miguel Prudêncio, Gerhard Bringmann et al. · 2015 · The Journal of Immunology
64. Antibody and T ‐cell responses associated with experimental human malaria infection or vaccination show limited relationships
    Karen Walker, Shinji L. Okitsu, David W. Porter, Christopher James Arthur Duncan, Mario Amacker, Gerd Pluschke, David R Cavanagh, Adrian V. S. Hill, Stephen M. Todryk · 2014 · Immunology
65. Generation of Rodent Malaria Parasites with a High Mutation Rate by Destructing Proofreading Activity of DNA Polymerase δ
    Hajime Honma, Makoto Hirai, Shota Nakamura, Hassan Hakimi, Shin‐ichiro Kawazu, Nirianne Palacpac, Hajime Hisaeda, Hiroyuki Matsuoka, Satoru Kawai, Hiroyoshi Endo et al. · 2014 · DNA Research
66. Tailoring a Combination Preerythrocytic Malaria Vaccine
    Karolis Bauza, Erwan Atcheson, Tomas Malinauskas, Andrew M. Blagborough, Arturo Reyes‐Sandoval · 2015 · Infection and Immunity
67. Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein
    Cate Speake, Alexander V. Pichugin, Tejram Sahu, Vlad Malkov, Robert Morrison, Ying Pei, Laure Y. Juompan, Neta Milman, Stasya Zarling, Charles Anderson et al. · 2016 · PLoS ONE
68. Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda
    Masanori Yagi, Nirianne Palacpac, Kazuya Ito, Yuko Oishi, Sawako Itagaki, Betty Balikagala, Edward Hosea Ntege, Adoke Yeka, Bernard N. Kanoi, Osbert T. Katuro et al. · 2016 · Scientific Reports
69. Newer Vaccines against Mosquito-borne Diseases
    Anju Aggarwal, Neha Garg · 2017 · The Indian Journal of Pediatrics
70. Vaccine innovations for emerging infectious diseases—a symposium report
    Jennifer Cable, Padmini Srikantiah, James E. Crowe, Bali Pulendran, Adrian V. S. Hill, Ann M. Ginsberg, Wayne Chester Koff, Anuja Mathew, Tony W. Ng, Kathrin Ute Jansen et al. · 2019 · Annals of the New York Academy of Sciences
71. Infectious Sporozoites of Plasmodium berghei Effectively Activate Liver CD8α+ Dendritic Cells
    Rajesh Parmar, Hardik Patel, Naveen Yadav, Ritika Parikh, Khyati Patel, Aditi Mohankrishnan, Vishakha Bhurani, Urja Joshi, Sarat Kumar Dalai · 2018 · Frontiers in Immunology
72. Virus-like antigen display for cancer vaccine development, what is the potential?
    Adam Frederik Sander, Pier‐Luigi Lollini · 2018 · Expert Review of Vaccines
73. Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case–control study
    Gemma Moncunill, Jason Carnes, William Chad Young, Lindsay N. Carpp, Stephen C. De Rosa, Joseph J. Campo, Augusto J. Nhabomba, Maximillian Mpina, Chenjerai Jairoce, Greg Finak et al. · 2021 · eLife
74. A non-replicative antibiotic resistance-free DNA vaccine delivered by the intranasal route protects against canine leishmaniasis
    Ana Alonso, Pedro J. Alcolea, Jaime Larraga, María Paz Peris, Adriana Esteban, Alberto Cortés, Silvia Ruiz-García, Juan Antonio Castillo, Vicente Larraga · 2023 · Frontiers in Immunology
75. A systematic review on malaria and dengue vaccines for the effective management of these mosquito borne diseases: Improving public health
    H. Alosaimi, M. Kanan, Lujain Marghlani, Badria Al-Rowaili, Reem Albalawi, A. Saad, Saba Alasmari, Khaled Althobaiti, Zainab Alhulaili, Abeer Alanzi et al. · 2024 · Human Vaccines & Immunotherapeutics
76. In silico identification of genetically attenuated vaccine candidate genes for Plasmodium liver stage
    Hirdesh Kumar, Friedrich Frischknecht, Gunnar Rudolf Mair, James Gomes · 2015 · Infection Genetics and Evolution
77. Generation and functional characterisation of Plasmodium yoelii csp deletion mutants using a microhomology-based CRISPR/Cas9 method
    Ruixue Xu, Yanjing Liu, Ruoxi Fan, Rui Liang, Lixia Yue, Shengfa Liu, Xin‐zhuan Su, Jian Li · 2019 · International Journal for Parasitology
78. Anopheles gambiae Lacking AgTRIO Inefficiently Transmits Plasmodium berghei to Mice
    Yu-Min Chuang, Marianna Freudzon, Jing Yang, Yuemei Dong, George Dimopoulos, Erol Fikrig · 2019 · Infection and Immunity
79. Discovery of pyridyl-based inhibitors of Plasmodium falciparum N -myristoyltransferase
    Zhiyong Yu, J.A. Brannigan, Kaveri Rangachari, William P. Heal, Anthony J. Wilkinson, Anthony A. Holder, Robin J. Leatherbarrow, Edward W. Tate · 2015 · MedChemComm
80. Local tolerance and systemic toxicity of single and repeated intramuscular administrations of two different formulations of the RTS,S malaria candidate vaccine in rabbits
    Lawrence M. Segal, Danielle Morelle, Mark Blee, Emma Moore, Micaela C. Damsten, Kai Chiu Liu, Éric Destexhe, Nathalie Garçon · 2014 · Regulatory Toxicology and Pharmacology
81. Malaria Vaccines: Current Achievements and Path Forward
    Jiayan Chen, Qi Wang, Xiaomeng He, Bei Yang · 2025 · Vaccines
82. Cryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitope
    Prabhanshu Tripathi, Michael F. Bender, Haotian Lei, Lais Da Silva Pereira, Chen‐Hsiang Shen, Brian G. Bonilla, Marlon Dillon, Li Ou, Marie Pancera, Lawrence Wang et al. · 2023 · Structure
83. Viral protein-based nanoparticles (part 2): Pharmaceutical applications
    Rocio Mellid-Carballal, Sara Gutierrez-Gutierrez, Carmen Rivas, Marcos García-Fuentes · 2023 · European Journal of Pharmaceutical Sciences
84. CD8+ T Cell Responses to Plasmodium and Intracellular Parasites
    Nicolás F. Villarino, Nathan W. Schmidt · 2014 · Current Immunology Reviews
85. Novel approaches in antimalarial drug discovery
    Jana Held, Andrea Kreidenweiss, Benjamin G. Mordmüller · 2013 · Expert Opinion on Drug Discovery
86. Malaria vaccine research and development: the role of the WHO MALVAC committee
    Geoffrey A. T. Targett, Vasee Moorthy, Graham V. Brown · 2013 · Malaria Journal
87. New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model
    Keith J. Limbach, Maureen E. Stefaniak, Ping Chen, Noelle B. Patterson, Grant C. Liao, Shaojie Weng, Svetlana Krepkiy, Greg Ekberg, Holly Torano, Damodar Ettyreddy et al. · 2017 · Malaria Journal
88. Prediction Model for Antimalarial Activities of Hemozoin Inhibitors by Using Physicochemical Properties
    Farhana Mosaddeque, Shusaku Mizukami, Mohamed Gomaa Kamel, Awet Alem Teklemichael, Truong Van Dat, Satoshi Mizuta, Dinh Van Toan, Ali Mahmoud Ahmed, Nguyen Lam Vuong, Mohamed Tamer Elhady et al. · 2018 · Antimicrobial Agents and Chemotherapy
89. Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study
    Sara White, Steven A. Harvey, Graciela Meza‐Sánchez, Alejandro Llanos‐Cuentas, Mitchel Guzmán-Guzmán, Dionicia Gamboa, Joseph Michael Vinetz · 2018 · Malaria Journal
90. A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development
    Sakineh Pirahmadi, Sedigheh Zakeri, Navid Dinparast Djadid, Akram Abouie Mehrizi · 2021 · International Journal for Parasitology
91. Chronic Immune Activation and CD4+ T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy
    Dawit Wolday, Francis Maina Ndungu, Gloria P. Gómez-Pérez, Tobias F. Rinke de Wit · 2021 · Frontiers in Immunology
92. Memory B-Cell Responses Against Merozoite Antigens After Acute Plasmodium falciparum Malaria, Assessed Over One Year Using a Novel Multiplexed FluoroSpot Assay
    Peter Jahnmatz, Christopher Sundling, Victor Yman, Linnea Widman, Muhammad Asghar, Klara Sondén, Christine Stenström, Christian Smedman, Francis Maina Ndungu, Niklas Ahlborg et al. · 2021 · Frontiers in Immunology
93. How to induce protective humoral immunity against Plasmodium falciparum circumsporozoite protein
    Ilka Wahl, Hedda Wardemann · 2022 · The Journal of Experimental Medicine
94. Modeling the public health impact of malaria vaccines for developers and policymakers
    Julia K. Nunes, Vicky Cárdenas, Christian Loucq, Nicolás Maire, Thomas A. Smith, Craig Shaffer, Kårstein Måseide, Alan Brooks · 2013 · BMC Infectious Diseases
95. Genetic polymorphism and amino acid sequence variation in Plasmodium falciparum GLURP R2 repeat region in Assam, India, at an interval of five years
    Dinesh Kumar, Sunil Kumar Dhiman, Bipul Rabha, Diganta Goswami, Manab Deka, Lokendra Singh, Indra Baruah, Vijay Veer · 2014 · Malaria Journal
96. IFNγ Responses to Pre-erythrocytic and Blood-stage Malaria Antigens Exhibit Differential Associations With Past Exposure and Subsequent Protection
    Prasanna Jagannathan, Felistas Nankya, Cristina T. Stoyanov, Ijeoma G. Eccles-James, Esther Sikyomu, Kate Naluwu, Samuel Posian Wamala, Mayimuna Nalubega, Jessica J. Briggs, Katherine Bowen et al. · 2014 · The Journal of Infectious Diseases
97. Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform
    Nadine C. Salisch, Marija Vujadinovic, Esmeralda van der Helm, Dirk Spek, Lars Vorthoren, Jan Serroyen, Harmjan Kuipers, Hanneke Schuitemaker, Roland C. Zahn, Jerome H. H. V. Custers et al. · 2017 · PLoS ONE
98. Diversify and Conquer: The Vaccine Escapism of Plasmodium falciparum
    Alena Pance · 2020 · Microorganisms
99. Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development
    Yukiko Miyazaki, Catherin Marin-Mogollon, Takashi Imai, António M. Mendes, Rianne van der Laak, Angelika Sturm, Fiona J. A. Geurten, Shinya Miyazaki, Séverine Chevalley, Jai Ramesar et al. · 2020 · Frontiers in Cellular and Infection Microbiology
100. Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with protection
     Dídac Macià, Joseph J. Campo, Gemma Moncunill, Chenjerai Jairoce, Augusto J. Nhabomba, Maximilian Mpina, Hermann Sorgho, David Dosoo, Ousmane Traoré, Kwadwo Asamoah Kusi et al. · 2022 · JCI Insight